ATE512230T1 - Proteinherstellungsverfahren unter nutzung von yebf - Google Patents

Proteinherstellungsverfahren unter nutzung von yebf

Info

Publication number
ATE512230T1
ATE512230T1 AT05774845T AT05774845T ATE512230T1 AT E512230 T1 ATE512230 T1 AT E512230T1 AT 05774845 T AT05774845 T AT 05774845T AT 05774845 T AT05774845 T AT 05774845T AT E512230 T1 ATE512230 T1 AT E512230T1
Authority
AT
Austria
Prior art keywords
protein
fusion protein
yebf
polypeptide
further comprise
Prior art date
Application number
AT05774845T
Other languages
German (de)
English (en)
Inventor
Joel Weiner
Guijin Zhang
Original Assignee
Univ Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Alberta filed Critical Univ Alberta
Application granted granted Critical
Publication of ATE512230T1 publication Critical patent/ATE512230T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT05774845T 2004-08-18 2005-08-12 Proteinherstellungsverfahren unter nutzung von yebf ATE512230T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52212504P 2004-08-18 2004-08-18
PCT/CA2005/001249 WO2006017929A1 (en) 2004-08-18 2005-08-12 Protein production method utilizing yebf

Publications (1)

Publication Number Publication Date
ATE512230T1 true ATE512230T1 (de) 2011-06-15

Family

ID=35907194

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05774845T ATE512230T1 (de) 2004-08-18 2005-08-12 Proteinherstellungsverfahren unter nutzung von yebf

Country Status (7)

Country Link
US (1) US20060246539A1 (cg-RX-API-DMAC7.html)
EP (1) EP1791961B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008509682A (cg-RX-API-DMAC7.html)
AT (1) ATE512230T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005274628A1 (cg-RX-API-DMAC7.html)
CA (1) CA2576083A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006017929A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006050332A1 (de) 2006-10-25 2008-04-30 Wacker Chemie Ag DNS-Konstrukt und Verfahren zur fermentativen Herstellung von Fusionsproteinen
KR102084509B1 (ko) 2011-05-11 2020-03-05 칠드런'즈 메디컬 센터 코포레이션 변형 비오틴-결합 단백질, 그 융합 단백질 및 응용
WO2014124228A1 (en) 2013-02-07 2014-08-14 Children's Medical Center Corporation Protein antigens that provide protection against pneumococcal colonization and/or disease
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10435697B2 (en) * 2014-11-03 2019-10-08 Nanyang Technological University Recombinant expression system that senses pathogenic microorganisms
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US12351805B2 (en) 2015-11-19 2025-07-08 Northeastern University Method of making recombinant silk and silk-amyloid hybrid proteins using bacteria
US11365225B2 (en) 2015-11-19 2022-06-21 President And Fellows Of Harvard College Method of making recombinant silk and silk-amyloid hybrid proteins using bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
AU2018243910B2 (en) 2017-03-28 2025-04-10 The Children's Medical Center Corporation A multiple antigen presenting system (MAPS)-based staphylococcus aureus vaccine, immunogenic composition, and uses thereof
BR112019027387A8 (pt) 2017-06-23 2022-12-06 Univ Maryland Composições imunogênicas
BR112021004193A2 (pt) 2018-09-12 2021-05-25 Affinivax, Inc. vacinas pneumocócicas multivalentes
CN113164580B (zh) 2018-09-12 2025-06-10 儿童医疗中心公司 肺炎球菌融合蛋白疫苗
WO2020165874A1 (en) * 2019-02-15 2020-08-20 Oncosimis Biotech Private Limited A bacterial expression vector for enhanced protein secretion
CN113474361B (zh) * 2019-02-24 2023-11-14 昂科斯密斯生物技术私人有限公司 由细菌连续生产重组glp-1肽的方法
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
CA3231684A1 (en) 2021-09-09 2023-03-16 Affinivax, Inc. Multivalent pneumococcal vaccines

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1335357C (en) * 1987-10-30 1995-04-25 Timothy M. Rose Expression systems for preparation of polypeptides in prokaryotic cells
US5646016A (en) * 1991-02-06 1997-07-08 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin, thioredoxin-like molecules, and modified thioredoxin-like molecules
US6033877A (en) * 1995-11-02 2000-03-07 Research Foundation Of State University Of New York Peptide expression and delivery system
US6022952A (en) * 1998-04-01 2000-02-08 University Of Alberta Compositions and methods for protein secretion
US6733997B1 (en) * 1998-10-30 2004-05-11 National University Of Singapore Isolated nucleic acids encoding a secretory signal for expression and secretion of heterologous recombinant proteins
FI109361B (fi) * 1999-05-04 2002-07-15 Korpela Timo Mikrobinen proteiinin ilmentämisjärjestelmä
CA2414775A1 (en) * 2000-05-03 2001-11-08 Expressive Constructs, Inc. A method and device for improving protein stability and solubility
EP1343870A4 (en) * 2000-11-09 2005-07-13 Univ Queensland BACTERIAL EXPRESSION
US20040142429A1 (en) * 2001-01-25 2004-07-22 Grant Chris W.M. Method for the expression, purification, and structure recovery and handling of hydrophobic proteins, polypeptides or peptides
JP2004532033A (ja) * 2001-05-04 2004-10-21 コーネル リサーチ ファンデイション インコーポレイテッド 発現し難いタンパク質用の迅速に開裂可能なsumo融合タンパク質発現系
KR100447530B1 (ko) * 2001-08-14 2004-09-08 한국과학기술원 OmpF를 이용하여 목적 단백질을 대장균 세포외로분비생산하는 방법
US6790051B1 (en) * 2003-12-20 2004-09-14 Lear Corporation Connector for printed circuit board

Also Published As

Publication number Publication date
WO2006017929A1 (en) 2006-02-23
US20060246539A1 (en) 2006-11-02
CA2576083A1 (en) 2006-02-23
JP2008509682A (ja) 2008-04-03
AU2005274628A1 (en) 2006-02-23
EP1791961A4 (en) 2008-11-19
EP1791961B1 (en) 2011-06-08
EP1791961A1 (en) 2007-06-06

Similar Documents

Publication Publication Date Title
ATE512230T1 (de) Proteinherstellungsverfahren unter nutzung von yebf
PE20110310A1 (es) Axmi-115, axmi-113, axmi-005, axmi-163 y axmi-184: proteinas insecticidas
MY161892A (en) A method of obtaining a purified, biologically active heterologous protein
WO2002099067A3 (en) Gene expression and production of tgf-b proteins including bioactive mullerian inhibiting substance from plants
EA200600946A1 (ru) Способы продуцирования аполипопротеинов в трансгенных растениях
AU3944002A (en) Metabolic rate shifts in fermentations expressing recombinant proteins
DE60227653D1 (de) Verfahren zur herstellung von l-aminosäuren, unter verwendung von stämmen aus der familie der enterohalten
ATE326523T1 (de) Verfahren zur fermentativen herstellung von l- methionin
DE69906509D1 (de) Herstellung einzelner genprodukte eines chimären fusionsproteins durch spaltung mit überall vorkommenden endoproteasen
WO2005026375A3 (en) Recombinant carrier molecule for expression, delivery and purification of target polypeptides
ATE298794T1 (de) Verfahren zur herstellung und reinigung von sekretierten proteinen und herstellung von protein-arrays
JP2008509682A5 (cg-RX-API-DMAC7.html)
DE502007005530D1 (de) Mikroorganismenstamm zur Produktion von rekombinanten Proteinen
DE602004025011D1 (de) Verfahren zur herstellung rekombinanter proteine
ATE408016T1 (de) Verfahren zur herstellung und sekretion modifizierter peptide
ATE480624T1 (de) Yapsin-mangelmutantenstamm von hansenula polymorpha sowie verfahren zur herstellung rekombinanter proteine damit
WO2005021764A3 (en) A process for proteolytic cleavage and purification of recombinant proteins produced in plants
EA201000945A1 (ru) Конструирование системы секреции на основе sm-белков
ATE335826T1 (de) Proteinherstellung
DK1905839T3 (da) Fremgangsmåde til fermentativ fremstilling af proteiner
DE602004023408D1 (de) Agments unter verwendung einer e.coli-signalsequenz sowie verfahren zur massenproduktion des antikörperfragments
DE60021404D1 (de) System zur herstellung von proteinen
DE60219361D1 (de) Verfahren zur rekombinanten herstellung von plazenta wachstumsfaktor
WO2002002591A3 (en) Peptides for use in culture media
RU2015105274A (ru) СПОСОБ ПОЛУЧЕНИЯ БЕЛКОВ СЕМЕЙСТВА ЦИСТЕИНОВЫХ ПРОТЕАЗ ПШЕНИЦЫ (Triticum aestivum) И ПРЕПАРАТ БЕЛКА ТРИТИКАИН-АЛЬФА, ПОЛУЧЕННЫЙ ЭТИМ СПОСОБОМ

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties